ストックスクリーナーアプリを入手
2.94
2.44%
0.07
Hcw Biologics Inc (HCWB) 最新ニュース
HCW Biologics (NASDAQ: HCWB) registers PIPE, warrant shares - Stock Titan
HCW Biologics regains Nasdaq bid price compliance - scanx.trade
581,047 Common Stock of HCW Biologics Inc. are subject to a Lock-Up Agreement Ending on 20-AUG-2026. - marketscreener.com
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
HCWB Q1 2026 Earnings: EPS of $2.22 Smashes Consensus by 182.44% Despite No RevenueHigh Estimate Range - vinanet.vn
HCW Biologics (HCWB) Slides 8.4% to $2.68 as Key Support Level Comes into FocusDividend Arbitrage - Vinanet
HCW Biologics Q2 net loss widens to $5.2M despite revenue surge - scanx.trade
Form 8K HCW Biologics Inc For: 14 August By Investing.com - Investing.com Nigeria
HCW Biologics Inc. Q2 2026: Revenue $135.6K, EPS $(11.58) — 10-Q Summary - TradingView
HCW Biologics (HCWB) posts higher 2026 revenue but flags going-concern risk - Stock Titan
HCW Biologics Reports Second Quarter 2026 Financial Results and Updates HCW9302 Alopecia Areata Program, HCW11-018b Development and Financing Activities - Quiver Quantitative
HCW Biologics trial: 3 alopecia patients cut SALT scores 25%+ - Stock Titan
HCWB Q1 2026 Earnings: Surprise EPS of $2.22 vs. Expected Loss, Yet Shares Slip 3.06%Consensus Miss Rate - Vinanet
HCW Biologics Inc (HCWB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
HCWB Q1 2026 Earnings: EPS of $2.22 Surges Past Loss EstimatesEarnings Power Value - vinanet.vn
HCW Biologics (HCWB) completes $1.6M exempt equity and warrant sale - Stock Titan
HCW Biologics | D: Filing D - Moomoo
HCWB Q2'26 Earnings: EPS estimate is (1.98) USD - TradingView
Price to earnings forward of HCW Biologics Inc. – NASDAQ:HCWB - TradingView
HCW Biologics (HCWB) director buys stock, entitled to new warrants - Stock Titan
HCW Biologics Announces $1.6 Million Private Placement Financing - The Globe and Mail
HCWB Q1 2026 Earnings: Surprising Profitability Driven by Non-Operating GainsHigh Growth Earnings - vinanet.vn
HCW Biologics Raises $1.6 Million in Private Placement; Units Priced at $2.585 - TradingView
HCW Biologics Prices $1.6 Million Private Placement Offering - marketscreener.com
HCWB Looks 94.1% Undervalued on GF Value™ Amid Challenging Funda - GuruFocus
HCW Biologics prices $1.6M private placement offering By Investing.com - Investing.com Canada
HCW Biologics Inc. Announces Pricing of $1.6 Million Private Placement Offering - GlobeNewswire
HCW Biologics Plans to Put $1.6M Toward Three Drug Programs - Stock Titan
HCWB|HCW Biologics Inc|Price:2.640|Chg%:+0.140 - TradingKey
HCW Biologics Inc (HCWB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
HCW Biologics Inc (HCWB) Cash Flow - TradingKey
HCW Biologics (HCWB) Surges 6% as Shares Test Key Resistance Near $2.78Large Cap Trends - vinanet.vn
HCW Biologics Inc (HCWB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
HCW Biologics Inc (HCWB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
HCW Biologics Q1 2026 Earnings: Massive EPS Beat but Stock Plunges – Market Skepticism Over SustainabilityEPS Estimate Trend - vinanet.vn
TradingKey - TradingKey
HCWB|HCW Biologics Inc|Price:2.500|Chg%:-0.380 - TradingKey
HCWB Q1 2026 Earnings: Surprise Net Income Amid Pre-Revenue StatusGuidance Downgrade Alert - Vinanet
HCW Biologics Inc (HCWB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
HCW Biologics Inc (HCWB) Valuation: PE, PB & Fair Value Analysis - TradingKey
HCW Biologics Inc. Revenue Breakdown – NASDAQ:HCWB - TradingView
HCW Biologics Inc. (HCWB) Stock Price, News, Quote & History - Yahoo! Finance Canada
HCW Biologics seeks pre-IND meeting with FDA for HCW-11-018b - BioWorld News
HCW Biologics Inc. (HCWB) stock price, news, quote and history - Yahoo Finance UK
HCW Biologics’ Cancer Candidate Targets Tissue Factor in Solid Tumors - Stock Titan
HCW Biologics requests FDA meeting for HCW11-018b solid tumor candidate - scanx.trade
HCWB Q1 2026 Earnings: Significant EPS Surprise Driven by Non-Operating ItemsProfit Inflection Point - vinanet.vn
HCWB Q1 2026 Earnings: Strong EPS Beat Despite Zero Revenue; Stock DeclinesPerformance Review - vinanet.vn
HCW Biologics Q1 2026 Earnings: Positive EPS Surprise Overwhelmed by Revenue AbsenceEarnings Beat Alert - dars.gov.et
HCW Biologics (HCWB) seeks $5.6M in stock sale to fund trials, repay debt - Stock Titan
HCWB Q1 2026 Earnings: A Surprise EPS Beat Masks Operational ChallengesNon-GAAP Earnings - Vinanet
HCWB Q1 2026 Earnings: EPS Surge on Non-Operating Items Overshadows Lack of RevenueBalance Sheet Strength - dars.gov.et
HCW Biologics Inc. Q1 2026 Earnings: Surprise EPS Beat Amidst No RevenuePre-Earnings Drift - DonanımHaber
HCW Biologics (HCWB) Declines 3.25% as Shares Approach Key Support LevelDonchian Channel - dars.gov.et
MSN Money - MSN
HCW Biologics (HCWB) Drops 8%: Testing Support Levels After Sharp DeclineSynthetic Long - dars.gov.et
HCW Biologics Regains Nasdaq Compliance, Plans Reverse Split - The Globe and Mail
HCW Biologics (HCWB) clears $2.8M disputes and $1.1M lien - Stock Titan
HCW Biologics Inc.: Top Mutual Funds Holders | QNCX | US40423R3030 - marketscreener.com
HCW Biologics Inc.: Fundamental Analysis and Financial Ratings | QNCX | US40423R3030 - marketscreener.com
HCW Biologics Inc.: Dividend historical data and projections - marketscreener.com
0.86%
0.31%
大文字化:
|
ボリューム (24 時間):